88 related articles for article (PubMed ID: 19585507)
1. The potential impact of human papillomavirus vaccination in contemporary cytologically screened populations may be underestimated: an observational retrospective analysis of invasive cervical cancers.
Powell N; Boyde A; Tristram A; Hibbitts S; Fiander A
Int J Cancer; 2009 Nov; 125(10):2425-7. PubMed ID: 19585507
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.
Wheeler CM; Hunt WC; Joste NE; Key CR; Quint WG; Castle PE
J Natl Cancer Inst; 2009 Apr; 101(7):475-87. PubMed ID: 19318628
[TBL] [Abstract][Full Text] [Related]
4. Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
Brotherton JML; Tabrizi SN; Phillips S; Pyman J; Cornall AM; Lambie N; Anderson L; Cummings M; Payton D; Scurry JP; Newman M; Sharma R; Saville M; Garland SM
Int J Cancer; 2017 Oct; 141(8):1576-1584. PubMed ID: 28677147
[TBL] [Abstract][Full Text] [Related]
5. Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines.
Cuschieri K; Brewster DH; Williams AR; Millan D; Murray G; Nicoll S; Imrie J; Hardie A; Graham C; Cubie HA
Br J Cancer; 2010 Mar; 102(5):930-2. PubMed ID: 20145611
[TBL] [Abstract][Full Text] [Related]
6. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis.
Bao YP; Li N; Smith JS; Qiao YL
Int J STD AIDS; 2008 Feb; 19(2):106-11. PubMed ID: 18334063
[TBL] [Abstract][Full Text] [Related]
8. Distribution of human papillomavirus genotypes in archival cervical tissue from women with cervical cancer in urban Sri Lanka.
Samarawickrema NA; Tabrizi SN; Hewavisenthi J; Leong T; Garland SM
Int J Gynaecol Obstet; 2011 Nov; 115(2):180-2. PubMed ID: 21872246
[TBL] [Abstract][Full Text] [Related]
9. HPV genotyping from invasive cervical cancer in Chile.
Roa JC; Garcia P; Gomez J; Fernández W; Gaete F; Espinoza A; Lepetic A; Suarez E
Int J Gynaecol Obstet; 2009 May; 105(2):150-3. PubMed ID: 19249046
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of high-risk human papillomavirus type 16 and 18 in oral and cervical cancers in population from Gujarat, West India.
Patel KR; Vajaria BN; Begum R; Desai A; Patel JB; Shah FD; Shukla SN; Patel PS
J Oral Pathol Med; 2014 Apr; 43(4):293-7. PubMed ID: 24372728
[TBL] [Abstract][Full Text] [Related]
11. Human Papillomavirus-Related Cancers.
Li Y; Xu C
Adv Exp Med Biol; 2017; 1018():23-34. PubMed ID: 29052130
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus type distribution in cervical cancer in Delhi, India.
Bhatla N; Dar L; Patro AR; Kriplani A; Gulati A; Verma K; Broor S; Shah KV; Gravitt PE
Int J Gynecol Pathol; 2006 Oct; 25(4):398-402. PubMed ID: 16990719
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
Berman TA; Schiller JT
Cancer; 2017 Jun; 123(12):2219-2229. PubMed ID: 28346680
[TBL] [Abstract][Full Text] [Related]
14. Unique human papillomavirus-type distribution in South African women with invasive cervical cancer and the effect of human immunodeficiency virus infection.
van Aardt MC; Dreyer G; Pienaar HF; Karlsen F; Hovland S; Richter KL; Becker P
Int J Gynecol Cancer; 2015 Jun; 25(5):919-25. PubMed ID: 25950128
[TBL] [Abstract][Full Text] [Related]
15. Modern screening in cervical cancer. Perspectives of HPV prophylactic vaccines.
Vlădăreanu R; Andrei C
Rev Med Chir Soc Med Nat Iasi; 2007; 111(1):144-54. PubMed ID: 17595860
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancers associated with human papillomavirus types 16, 18 and 45 are diagnosed in younger women than cancers associated with other types: a cross-sectional observational study in Wales and Scotland (UK).
Powell N; Cuschieri K; Cubie H; Hibbitts S; Rosillon D; De Souza SC; Molijn A; Quint W; Holl K; Fiander A
J Clin Virol; 2013 Nov; 58(3):571-4. PubMed ID: 24051043
[TBL] [Abstract][Full Text] [Related]
17. Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007.
Alemany L; de Sanjosé S; Tous S; Quint W; Vallejos C; Shin HR; Bravo LE; Alonso P; Lima MA; Guimerà N; Klaustermeier J; Llombart-Bosch A; Kasamatsu E; Tatti SA; Felix A; Molina C; Velasco J; Lloveras B; Clavero O; Lerma E; Laco J; Bravo IG; Guarch R; Pelayo A; Ordi J; Andújar M; Sanchez GI; Castellsagué X; Muñoz N; Bosch FX;
Int J Cancer; 2014 Jul; 135(1):88-95. PubMed ID: 24382655
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus genotype distribution among Cameroonian women with invasive cervical cancer: a retrospective study.
Pirek D; Petignat P; Vassilakos P; Gourmaud J; Pache JC; Rubbia-Brandt L; Sando Z; McKee TA; Ho L
Sex Transm Infect; 2015 Sep; 91(6):440-4. PubMed ID: 25746041
[TBL] [Abstract][Full Text] [Related]
19. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
Jenkins D
Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
[TBL] [Abstract][Full Text] [Related]
20. Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer.
Geraets D; Alemany L; Guimera N; de Sanjose S; de Koning M; Molijn A; Jenkins D; Bosch X; Quint W;
J Pathol; 2012 Dec; 228(4):534-43. PubMed ID: 22711526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
